These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6396047)

  • 1. [Treatment of congestive heart failure with captopril].
    Zheng DY
    Zhonghua Nei Ke Za Zhi; 1984 Jan; 23(1):5-9, 61. PubMed ID: 6396047
    [No Abstract]   [Full Text] [Related]  

  • 2. [Captopril in the treatment of severe congestive heart failure. Experience with 10 patients].
    Escobar E; Ojeda G; Saavedra M; Thumala A
    Rev Med Chil; 1983 Nov; 111(11):1123-9. PubMed ID: 6379801
    [No Abstract]   [Full Text] [Related]  

  • 3. [A clinical study on treatment of refractory heart failure with oral captopril].
    Wang ZS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1983 Dec; 11(4):269-72. PubMed ID: 6370641
    [No Abstract]   [Full Text] [Related]  

  • 4. Factors predicting acute and long-term response to captopril therapy in congestive heart failure.
    Levine TB; Cohn JN
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):169S-174S. PubMed ID: 6753898
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of captopril in circulatory failure].
    Mareev VIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):109-14. PubMed ID: 6753872
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of severe chronic cardiac congestive insufficiency with captopril. Short and long-term clinical, hemodynamic and biological effects].
    Lavigne G; Morand P
    Arch Mal Coeur Vaiss; 1982 Mar; 75(3):339-48. PubMed ID: 6807251
    [No Abstract]   [Full Text] [Related]  

  • 7. Beneficial haemodynamic effect of the angiotensin blocking agent captopril in patients with refractory heart failure.
    Lee CL; MacDonald GJ; Walsh WF
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():93-7. PubMed ID: 6291831
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical, hemodynamic, plethysmographic and biological effects of the oral converting enzyme inhibitor, captopril (SQ 14225), in the short and medium-team treatment of advanced congestive cardiac failure].
    Kayanakis JG; Fauvel JM; Giraud P; Boccalon H; Puel J; Cassagneau B; Bounhoure JP
    Arch Mal Coeur Vaiss; 1981 Nov; 74(11):1325-32. PubMed ID: 6797371
    [No Abstract]   [Full Text] [Related]  

  • 9. [Captopril in chronic congestive heart failure--dose-effect behavior and comparison with prazosin].
    Froer KL; Hall D; Rudolph W
    Herz; 1983 Apr; 8(2):81-7. PubMed ID: 6343211
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute and chronic effects of captopril therapy in patients with refractory heart failure.
    Walsh WF; Lee CL
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):153S-159S. PubMed ID: 6753896
    [No Abstract]   [Full Text] [Related]  

  • 11. [Acute effects of angiotensin I converting enzyme inhibitor, captopril (SQ 14, 225) on severe heart failure--hemodynamics, plasma catecholamine levels, renin-angiotensin-aldosterone system and blood gas data (author's transl)].
    Morimoto Y; Baba M; Takahashi T; Fujii M; Konishi T; Kawanami C; Hamada M; Nakano T; Takezawa H
    Kokyu To Junkan; 1982 Mar; 30(3):317-25. PubMed ID: 6808624
    [No Abstract]   [Full Text] [Related]  

  • 12. [Captopril in the treatment of chronic congestive heart failure].
    Grajek S; Jasiński K
    Kardiol Pol; 1984; 27(3):225-41. PubMed ID: 6376905
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of the treatment of heart failure with captopril].
    Morand P; Lavigne G
    Nouv Presse Med; 1981 Apr; 10(19):1591. PubMed ID: 7025851
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute and long-term response to an oral converting-enzyme inhibitor, captopril, in congestive heart failure.
    Levine TB; Franciosa JA; Cohn JN
    Circulation; 1980 Jul; 62(1):35-41. PubMed ID: 6247102
    [No Abstract]   [Full Text] [Related]  

  • 15. Short and long-term effects of treatment with low dose captopril in patients with severe congestive heart failure.
    Dahlström U; Karlberg BE
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):231S-235S. PubMed ID: 6753905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of congestive heart failure with captopril.
    Komajda M; Eugene M; Evans J; Drobinski G; Laurenceau JL; Grosgogeat Y
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):223S-229S. PubMed ID: 6753904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperkinetic circulation associated with captopril therapy for congestive heart failure.
    Fouad FM; Salcedo EE; Saragoca M; Bravo EL; Tarazi RC
    N Engl J Med; 1981 Aug; 305(7):405-6. PubMed ID: 7019709
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term treatment of congestive heart failure by captopril: hemodynamic, biological and clinical effects.
    Kayanakis JG; Fauvel JM; Giraud P; Bounhoure JP
    Eur Heart J; 1981 Feb; 2(1):75-81. PubMed ID: 7023947
    [No Abstract]   [Full Text] [Related]  

  • 19. Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.
    Dzau VJ; Colucci WS; Williams GH; Curfman G; Meggs L; Hollenberg NK
    N Engl J Med; 1980 Jun; 302(25):1373-9. PubMed ID: 6246425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Favorable hemodynamic effects of captopril in chronic refractory cardiac decompensation].
    Ansalone G; Bellocci F; Scabbia E; Schiavoni G; Loperfido F; Zecchi P
    Cardiologia; 1982; 27(3):263-9. PubMed ID: 6765277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.